Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, Synthesis, and Biological Evaluation of SSE1806, a Microtubule Destabilizer That Overcomes Multidrug Resistance.
Firdous F, Riaz S, Furqan M, Fozail S, Fatima K, Pohl SÖ, Doleschall NJ, Myant KB, Kahfi J, Emwas AH, Jaremko M, Chotana GA, Saleem RSZ, Faisal A. Firdous F, et al. Among authors: furqan m. ACS Med Chem Lett. 2023 Sep 8;14(10):1369-1377. doi: 10.1021/acsmedchemlett.3c00258. eCollection 2023 Oct 12. ACS Med Chem Lett. 2023. PMID: 37849542
Barriers to accessing neurosurgical care in low- and middle-income countries from Africa: editorial.
Okon II, Akilimali A, Furqan M, Precious FK, Gbayisomore TJ, Atallah O, Erhayanmen MO, Christopher EC, Umutoni F, Nkeshimana M, Lucero-Prisno DE 3rd. Okon II, et al. Among authors: furqan m. Ann Med Surg (Lond). 2024 Jan 25;86(3):1247-1248. doi: 10.1097/MS9.0000000000001758. eCollection 2024 Mar. Ann Med Surg (Lond). 2024. PMID: 38463130 Free PMC article. No abstract available.
The current state of neurosurgical care in Africa - a correspondence.
Oduoye MO, Riaz R, Khan A, Okon II, Akpan U, Bello IM, Munsab R, Furqan M, Akilimali A. Oduoye MO, et al. Among authors: furqan m. Neurosurg Rev. 2024 Apr 11;47(1):149. doi: 10.1007/s10143-024-02398-w. Neurosurg Rev. 2024. PMID: 38600422 No abstract available.
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Rodón J, Damian S, Furqan M, García-Donas J, Imai H, Italiano A, Spanggaard I, Ueno M, Yokota T, Veronese ML, Oliveira N, Li X, Gilmartin A, Schaffer M, Goyal L. Rodón J, et al. Among authors: furqan m. Nat Med. 2024 May 24. doi: 10.1038/s41591-024-03072-w. Online ahead of print. Nat Med. 2024. PMID: 38789647 No abstract available.
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.
Abu Hejleh T, AlSawalha K, Abdel Hafiz S, Al-Batsh T, Abu Hejleh R, Yaser S, Abu Jazar H, Khader J, Alnsour A, Mohamad I, Abdel Jalil R, Abu-Shanab A, Gharaibeh A, Abu Shattal M, Alibraheem A, Haddad H, Mahmoud N, Obeidat S, Al-Jaghbeer MJ, Furqan M, Cortellini A, Velcheti V, Al-Rabi K. Abu Hejleh T, et al. Among authors: furqan m. Front Oncol. 2024 Apr 30;14:1369126. doi: 10.3389/fonc.2024.1369126. eCollection 2024. Front Oncol. 2024. PMID: 38746680 Free PMC article.
123 results